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Disrupted-In-Schizophrenia 1 (DISC1) was identified as a risk factor for psychiatric illness through its disrup-
tion by a balanced chromosomal translocation, t(1;11)(q42.1;q14.3), that co-segregates with schizophrenia,
bipolar disorder and depression. We previously reported that the translocation reduces DISC1 expression,
consistent with a haploinsufficiency disease model. Here we report that, in lymphoblastoid cell lines, the
translocation additionally results in the production of abnormal transcripts due to the fusion of DISC1 with
a disrupted gene on chromosome 11 (DISC1FP1/Boymaw). These chimeric transcripts encode abnormal pro-
teins, designated CP1, CP60 and CP69, consisting of DISC1 amino acids 1–597 plus 1, 60 or 69 amino acids,
respectively. The novel 69 amino acids in CP69 induce increased a-helical content and formation of large
stable protein assemblies. The same is predicted for CP60. Both CP60 and CP69 exhibit profoundly altered
functional properties within cell lines and neurons. Both are predominantly targeted to mitochondria,
where they induce clustering and loss of membrane potential, indicative of severe mitochondrial dysfunction.
There is currently no access to neural material from translocation carriers to confirm these findings, but there
is no reason to suppose that these chimeric transcripts will not also be expressed in the brain. There is thus
potential for the production of abnormal chimeric proteins in the brains of translocation carriers, although at
substantially lower levels than for native DISC1. The mechanism by which inheritance of the translocation
increases risk of psychiatric illness may therefore involve both DISC1 haploinsufficiency and mitochondrial
deficiency due to the effects of abnormal chimeric protein expression.
GenBank accession numbers: DISC1FP1 (EU302123), Boymaw (GU134617), der 11 chimeric transcript
DISC1FP1 exon 2 to DISC1 exon 9 (JQ650115), der 1 chimeric transcript DISC1 exon 4 to DISC1FP1 exon 4
(JQ650116), der 1 chimeric transcript DISC1 exon 6 to DISC1FP1 exon 3a (JQ650117).
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INTRODUCTION
We identified Disrupted-In-Schizophrenia 1 (DISC1) as a
genetic risk factor for major mental illness, through study of
a large Scottish family multiply affected with schizophrenia,
bipolar disorder and major depressive disorder, that results
from inheritance of a balanced t(1;11)(q42.1;q14.3) chromo-
somal translocation (1). On chromosome 1, the t(1;11) trans-
location directly disrupts DISC1 and its non-coding antisense
partner DISC2 (2). Perturbed expression of one or both
genes is therefore likely to be directly involved in disease
pathogenesis. Independent genetic linkage and association
data support the involvement of the DISC locus in schizophre-
nia, schizoaffective disorder, bipolar disorder, recurrent major
depression, and most recently autism spectrum disorders, in
multiple populations (3,4).
DISC1 is a scaffold protein now known to be essential for
many critical brain processes, including regulation of neural
precursor proliferation and differentiation (5), migration of
newborn neurons within the developing cortex (6) and adult
hippocampus (7), integration of newborn neurons into the
existing neural circuitry (7), modulation of dendritic spines
(8) and synapse formation/composition (7,9). If dysregulated
by the t(1;11) translocation through the disruption of DISC1,
it is conceivable that any or all of these processes could con-
tribute to abnormal brain development and function, thereby
triggering psychiatric illness.
Although we have previously provided evidence for haploin-
sufficiency as the disease mechanism in translocation carriers
(10), we now provide evidence for an additional level of com-
plexity. The translocation fuses DISC1 to a gene on chromo-
some 11, DISC1 Fusion Partner 1 (DISC1FP1), also known
as Boymaw (11), resulting in the production of various aberrant
chimeric transcripts with novel protein-coding potential. The
proteins encoded by these transcripts consist of C-terminally
truncated DISC1—in some instances fused to 1, 60 or 69
novel amino acids encoded by the DISC1FP1 sequence. The
60 and 69 additional amino acids increase the a-helical
content of DISC1 in vitro, resulting in the formation of abnor-
mally large protein assemblies that exhibit increased thermal
stability. When exogenously expressed, these abnormal chimer-
ic proteins are predominantly targeted to mitochondria, where
they induce abnormal morphology and abolish mitochondrial
membrane potential. Overall, our data suggest that dysregulated
mitochondrial function in proliferating cells and neurons may
contribute to disease pathogenesis in translocation carriers.
RESULTS
Abnormal chimeric DISC1 transcripts result from the
t(1;11) translocation
A gene referred to as Boymaw has previously been noted as
spanning the chromosome 11 translocation breakpoint in the
t(1:11) family (11). Analysis of expressed sequence tags
(ESTs) indicates that transcripts produced from this gene
(Fig. 1A) are alternatively spliced, utilizing multiple alterna-
tive exons and, in exon 5, alternative splice donor sites
(Fig. 1B). This gene possesses no significant open reading
frames (ORFs) and is therefore most likely a non-coding
RNA gene.
DISC1 and the chromosome 11 gene are oriented such that
the translocation causes gene fusion. Consequently, in lym-
phoblastoid cell lines, the derived 1 and 11 chromosomes
(der 1 and der 11) may give rise to chimeric transcripts con-
sisting of DISC1 exons 1–8 fused to breakpoint distal exons
of the chromosome 11 gene, or to breakpoint proximal
exons of the chromosome 11 gene fused with DISC1 exons
9–13, respectively (11).
Analysis of chimeric transcript expression using lympho-
blastoid cell lines derived from t(1;11) translocation carriers
demonstrated that such transcripts are indeed produced
(Fig. 2A). Thus, the disrupted gene on chromosome 11 has
been officially named DISC1 Fusion Partner 1 (DISC1FP1)
(12) to reflect this biological mechanism, although it has also
been referred to using the AceView (13) name Boymaw (11).
Reverse transcription PCR (RT-PCR) analysis using primer
pairs designed to amplify chimeric transcripts from both the
der 1 and der 11 chromosomes combined with sequencing
detected the fusion of DISC1 exon 9 to DISC1FP1 exon 3a
or exon 4, as well as the fusion of DISC1FP1 exon 2 to
DISC1 exon 8 in cell lines carrying the translocation (Fig. 2A).
Breakpoint proximal, but not distal, DISC1 transcript
levels are reduced by the t(1;11) translocation
We have previously demonstrated that DISC1 transcription
occurs from the disrupted DISC1 allele on chromosome 1,
and that DISC1 transcript levels, quantified using PCR
primers specific for exon 2, are reduced (10). In this extended
study, we used SYBR green real-time PCR to quantify DISC1
expression in lymphoblastoid cell lines derived from t(1;11)
family members, utilizing primer pairs designed proximal to
the translocation breakpoint, either within exon 2 or spanning
exons 4–6 (detecting wild-type DISC1 transcripts plus tran-
scripts produced from the der 1 chromosome), or distal to the
translocation breakpoint, within exon 9 (detecting wild-type
Figure 1. Schematic of DISC1FP1 (not to scale). (A) DISC1FP1 genomic
structure showing all known exons (numbered according to 11 and 34).
Arrow indicates alternatively spliced exon 5. (B) ESTs from DISC1FP1.
Asterisks mark positions of translation stop codons predicted to be utilized
in chimeric transcripts arising from the der 1 chromosome. CK000409 and
BU599486 encode CP60 and CP69, respectively, both terminating within
exon 6. AB371558 encodes CP1, which terminates within exon 3a.
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DISC1 transcripts plus transcripts produced from the der 11
chromosome).
We confirmed the reduction in DISC1 transcript expres-
sion levels using primer pairs proximal to the t(1;11) break-
point (Fig. 2B, P , 0.05 for exon 2 primers, P, 0.01 for
exon 4–6 primers). In contrast, the exon 9 primers did not
detect a decrease in DISC1 expression in translocation car-
riers compared with normal karyotype controls (Fig. 2B). Al-
together, assuming that DISC1 expression from the
non-disrupted allele is unaltered by the translocation, these
quantitative data demonstrate that chimeric transcripts pro-
duced from the der 1, but not the der 11, chromosome are
scarce. The der 1 chimeric transcripts are predicted to
have splice junctions downstream of the translation stop
codon (Fig. 1B), a feature of aberrant transcripts that
marks them for nonsense-mediated mRNA decay (14).
These transcripts may therefore be targeted and degraded
by this cellular surveillance mechanism and depleted from
the cell. In contrast, there are no obvious stability issues
for chimeric transcripts from the der 11 chromosome. This
interpretation is complicated by the theoretical possibility
that the exon 9 primer pair also detects DISC2 transcripts,
which overlap DISC1 exon 9, although DISC2 is expressed
at unquantifiably low levels in lymphoblastoid cell lines
(data not shown).
The translocation-carrying cell lines used in this analysis
were derived from one unaffected carrier, and one and four
carriers diagnosed with schizophrenia or severe recurrent de-
pression, respectively. Although the sample numbers are
low, it is worth pointing out that the quantitative measures
Figure 2. Chimeric transcript expression in t(1;11) family-derived lymphoblastoid cell lines. (A) RT-PCR detects chimeric transcripts in translocation cell lines.
(Left) Schema of the fused genes on each derived chromosome. Black and grey boxes represent DISC1 and DISCFP1 exons, respectively. Arrows denote primers
used in this analysis. (Middle) Amplified PCR products. 2VE, N and T represent negative controls, normal karyotype cell lines and translocation cell lines,
respectively. The DISC1FP1 exon 2-DISC1 exon 9 primer pair generated two products corresponding to the inclusion/exclusion of the alternatively spliced
DISC1FP1 exon 3. Data from the DISC1 exon 7-DISC1FP1 exon 3a primer pair are shown as three lanes spliced together from a single gel. (Right)
RT-PCR products were sequenced to confirm chimeric transcript amplification. (B) Real-time PCR quantification of DISC1 expression levels. Each dot repre-
sents a single cell line. Open, black and grey circles represent no diagnosis, schizophrenia and recurrent major depression, respectively. Horizontal lines represent
the mean of each group. Statistical significance was determined independently for each primer pair using a two-tailed t-test to compare the group mean expres-
sion levels.
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gave no indication of a relationship between DISC1 transcript
levels and diagnosis.
Predicted abnormal DISC1 protein species encoded by the
chimeric transcripts
Transcripts fusing DISC1 exons 1–8 with DISC1FP1 exons
4-end encode abnormal proteins consisting of DISC1 amino
acids 1–597 fused at the C-terminus to novel amino acids
encoded by DISC1FP1. Alternative splicing of DISC1FP1
exon 5 induces a frameshift, resulting in the addition of 60
or 69 novel amino acids (Table 1). These proteins will be re-
ferred to as Chimeric Protein 60 and 69 (CP60 and CP69).
Transcripts fusing DISC1 exons 1–8 with DISC1FP1 exon
3a encode DISC1 amino acids 1–597, plus a single glycine
derived from the DISC1FP1 sequence (Table 1). This
protein will be referred to as CP1. Since there is normally a
glycine at position 598 in DISC1, CP1 essentially corresponds
to DISC1 amino acids 1–598.
Chimeric transcripts produced from the der 11 chromosome
contain an internal ORF corresponding to amino acids 669–
854 of the DISC1 C-terminus. This ORF is unlikely to be
translated because DISC1FP1 is apparently non-coding; there-
fore, the sequence upstream of the DISC1 ORF is unlikely to
provide the signals necessary for translation initiation.
Fusion protein 69 exhibits altered structure and thermal
stability
We speculated that the addition of 60 or 69 novel amino acids
would alter the properties of the N-terminal DISC1 fragment
encoded by the chimeric transcripts. We selected DISC1
Table 1. Abnormal DISC1 protein species encoded by transcripts produced from the der 1 chromosome
Nucleotide sequences are shown above, and the corresponding translated amino acid sequence below. Der 1-derived chimeric transcripts are predicted to contain
DISC1 exons 1–8, encoding amino acids 1–597, but for simplicity only amino acids 593–597 are shown. DISC1-derived nucleotides are in lower case, the codon
and amino acid (glycine) at the junction are in bold type, lower case italics denote the alternatively spliced region at the 3′ end of DISC1FP1 exon 5 (the short and
long forms of the exon are designated 5S and 5L, respectively) and underlining marks the alternative amino acids within CP60 and CP69.
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amino acids 326–597 for analysis, fused to maltose-binding
protein (MBP) tags, based upon considerations of domain delin-
eation, predicted protein disorder in the N-terminus of native
DISC1 and likely consequences for protein expression,
purification, and finally on the assessment of secondary struc-
ture for the C-terminus of native DISC1 (15). This DISC1
region was expressed both by itself (MBP-DN597) or fused to
the novel 69 amino acids of CP69 (MBP-DNCP69, Fig. 3A),
Figure 3. Biophysical characterization of CP69. (A) Schematic of the recombinant proteins MBP-DN597 and MBP-DNCP69, drawn to scale. (B) Following
amylose affinity purification, size exclusion chromatography separates the recombinant protein (140 ml peak) from co-purifying contaminants (later
peaks); CV: 320 ml. (C) SDS–PAGE purification gel of MBP-DN597 and MBP-DNCP69 proteins. AAP, amylose affinity purification; SEC, size exclusion chro-
matography. Arrows indicate monomers and dimers. (D) Mean hydrodynamic diameters of three independent protein preparations for each of MBP-DN597 and
MBP-DNCP69 determined by DLS. (E) Mean melting temperatures of three independent protein preparations for each of MBP-DN597 and MBP-DNCP69 deter-
mined by DLS at increasing temperatures. (F) CD spectra of MBP-DN597 (0.12 mg/ml) and MBP-DNCP69 (0.11 mg/ml) in the far-UV range is shown, with
mean residue ellipticity and wavelength (measured from 280 to 185 nm) plotted along the y-axis and x-axis, respectively. (G) Deconvolution of the CD spectra
using different algorithms and data sets.
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selected because it is the longest of the chimeric proteins.
Following purification from Escherichia coli, each product
was detectable as two major species (75 and 150 kDa for
MBP-DN597 and 80 and 160 kDa for MBP-DNCP69) on an
SDS–PAGE gel (Fig. 3B and C). The molecular weights of
these species correspond to the predicted molecular weights
of the protein monomers and SDS-resistant dimers (respective-
ly, 76.8 and 153.6 kDa for MBP-DN597, and 85.1 and
170.2 kDa for MBP-DNCP69). The identities of these species
were confirmed by mass spectrometry (Supplementary Mater-
ial, Figs S1 and S2).
Measurement of native purified protein size (hydrodynamic
diameter) using dynamic light scattering (DLS) revealed that
MBP-DNCP69 forms larger species compared with
MBP-DN597, although this fell just short of statistical signifi-
cance (P ¼ 0.056, Fig. 3D). In support of this, the initial size ex-
clusion chromatography also suggests that the MBP-DNCP69
assembly has a larger hydrodynamic diameter (Fig. 3B). The
thermal stability of each protein was then assessed by taking
DLS readings at steadily increasing temperatures and measur-
ing the point at which changes in protein structure occur.
MBP-DNCP69 exhibits a consistently higher melting point
than MBP-DN597 (P ¼ 0.003, Fig. 3E). Altogether, the
increased size and higher melting point of MBP-DNCP69
suggest that the addition of 69 novel amino acids induces the
formation of larger structures with increased stability.
Far-UV circular dichroism (CD) spectra were then recorded
to estimate the secondary structure content. Both MBP-DN597
and MBP-DNCP69 exhibit a pronounced double-negative
minimum at 208 and 222 nm and one positive peak at
193 nm in the far-UV range (Fig. 3F), a characteristic of
folded proteins with a high a-helical content (16). However,
MBP-DNCP69 displays significantly more pronounced nega-
tive and positive ellipticity centred in these regions, when
compared with MBP-DN597, implying a greater propensity
towards a-helices and indicating that secondary structure vari-
ation exists as a result of the novel 69 amino acids. Indeed,
upon spectral deconvolution using three combinations of algo-
rithms and reference sets (17–21), the MBP-DNCP69 struc-
ture is estimated to possess 1.4–1.8 times greater
a-helical content and lower b-strand composition compared
with MBP-DN597 (Fig. 3G).
Analysis of the novel 60 and 69 DISC1FP1 residues shows a
strong disagreement between three secondary structure predic-
tion programs (22–24) (Fig. 4); PsiPred predicts several low-
confidence b-strands for this region, whereas JPred3 and
Porter predict an abundance of a-helices. The CD spectroscopy
results revealing elevated a-helical content in MBP-DNCP69
are in agreement with the latter predictions. PCoils/Coils
(25,26) did not predict any coiled-coil motifs. Although the
presence of the MBP tag precludes direct comparison with
other CD studies that investigated the C-terminal region of
DISC1 (27), altogether these data imply an overall mixed a/b
fold for this region.
Thus, it appears that the addition of 69 amino acids from
DISC1FP1 introduces clear differences in secondary structure
compared with the control truncated DISC1 protein, resulting
in the formation of larger, more stable protein assemblies.
CP60 and CP69 are mitochondrial proteins that induce
mitochondrial dysfunction
DISC1 has been detected at multiple subcellular locations, in-
cluding the centrosome (28), nucleus (29), mitochondria (30),
Golgi (31) and synapse (32). C-terminally truncated DISC1
(amino acids 1–597) instead adopts a predominantly diffuse
cytoplasmic distribution (Fig. 5A) (6). In COS7 cells, FLAG-
tagged CP1 also adopts a diffuse cytoplasmic distribution
(Fig. 5A), confirming that these two proteins most likely have
highly similar properties.
FLAG-CP60 and FLAG-CP69, however, are strongly tar-
geted to mitochondria in COS7 cells, where they alter mitochon-
drial morphology from the normal extended tubular structure to
abnormal perinuclear clusters (Fig. 5A). Intriguingly, the major-
ity of these abnormal clustered mitochondria do not take up the
mitochondrial membrane potential-dependent dye mitotracker
(Fig. 5A), indicating that chimeric protein expression inhibits
normal mitochondrial function. Importantly, this loss of
membrane potential occurs even when the chimeric proteins
are exogenously expressed at the lowest levels detectable
using this method (Fig. 5A). However, co-staining with the
mitochondrial marker cytochrome c reveals that the mitochon-
dria remain intact (Fig. 5A). DISC1 has previously been
reported to induce mitochondrial dysfunction, including
altered mitochondrial NADH activity (33). This enzyme partici-
pates in oxidative phosphorylation, a process which generates
and maintains the mitochondrial membrane potential, thus the
loss of mitochondrial membrane potential in cells expressing
CP60 or CP69 possibly indicates a deleterious effect upon mito-
chondrial NADH activity. In cultured primary cortical neurons
from the CD1 mouse strain [days in vitro (DIV) 5], or the
C57BL/6 mouse strain (DIV 11), FLAG-CP60 and
FLAG-CP69 induce the same mitochondrial clustering and
the loss of membrane potential (Fig. 5B and Supplementary Ma-
terial, Fig. S3). Altogether, these data show that the altered bio-
physical properties demonstrated for CP69, and most likely
possessed by CP60 also, correlate with profoundly altered func-
tion within proliferating cells and neurons.
Figure 4. Secondary structure predictions for the DISC1FP1-derived amino
acids of CP60 and CP69, using three prediction programs: PsiPred3, JPred3
and Porter.
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Figure 5. Exogenous chimeric protein expression in COS7 cells and cultured CD1 mouse primary neurons. (A) Immunofluorescence detection of FLAG-tagged
DISC1 (green), mitochondria (MitoTracker Red CMXRos) and cytochrome c (pink) in COS7 cells. Asterisks indicate cells transfected with CP60 or CP69,
marking cells with low-, medium- or high-level expression. Scale bars represent 20 mm. (B) Immunofluorescence detection, as above, in primary mouse cortical
neurons. Asterisks indicate cells transfected with CP60 or CP69. Scale bars represent 10 mm.
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Investigating chimeric protein expression in
lymphoblastoid cell lines
Identification of DISC1 chimeric transcripts prompted us to re-
examine our previous report of reduced DISC1 protein expres-
sion as a result of the t(1;11) translocation (10). We expressed
untagged CP1, CP60 or CP69 in COS7 cells, and investigated
isoform expression using DISC1 antibody R47, specific for the
N-terminal head domain (30). This demonstrated that CP1 is
abundant in soluble lysates, whereas CP60 and CP69 partition
predominantly to the pellet produced during cell lysis
(Fig. 6A), as has been noted previously for a related DISC1
chimeric protein (34). However, a small proportion of each
chimeric protein is also detectable within the soluble lysates.
In addition to full-length DISC1, R47 detects a triplet of
species of 71–80 kDa (30). CP1 (predicted molecular
weight of 64.5 kDa) migrates between the 71 and 75 kDa
species, whereas CP60 and CP69 (predicted molecular
weights of 71.8 and 72.8 kDa, respectively) migrate between
the 75 and 80 kDa species, thus each chimeric protein is dis-
tinct from the endogenous species detected by R47 on immu-
noblots (Fig. 6B).
We next examined lymphoblastoid cell lines derived from
members of the t(1;11) family. Our previous analysis
focused on lysates, and did not detect any abnormal species
in translocation cell lines (10). In this study, we examined
pellets. The same triplet of bands at 71–80 kDa is detectable
in both lysates and pellets, with no additional species detect-
able in cell lines carrying the translocation (Fig. 6C). The
chimeric proteins are thus either not expressed, or are
present below the level of detection using this antibody. The
latter is consistent with the production, but apparent low ex-
pression/predicted short lifespan, of chimeric transcripts
from the der 1 chromosome.
We also used a-DISC1 (35), an antibody specific for a
translocation breakpoint distal DISC1 epitope that should
detect the C-terminal fragment, amino acids 669–854,
encoded by chimeric transcripts from the der 11 chromosome.
Although the antibody clearly detects full-length DISC1 in the
lymphoblastoid cell lines, it failed to detect any novel species
in translocation cell lines that could correspond to this frag-
ment (predicted molecular weight of 20.9 kDa, Fig. 6D).
Thus, as with the N-terminal chimeric proteins, this fragment
is either not expressed, or is present but below the detection
limit of the antibody.
DISCUSSION
Although the t(1;11) translocation is a unique genetic event,
understanding its molecular consequences in full may help
explain the very high penetrance of this mutation and inform
on other clinical mutations (15). Aberrant DISC1 proteins
putatively arising from the der 1 chromosome lack the final
257 amino acids, required for interaction with a number of
important binding partners, including NDE1/NDEL1 (15). C-
terminal truncation will thus abolish critical interactions
(36), while maintaining others that require amino acids 1–
Figure 6. Chimeric protein expression in t(1;11) family-derived lymphoblastoid cell lines. (A) Overexpressed untagged CP69 partitions predominantly to pellets
from transfected COS7 cells, as detected using antibody R47. L, lysate; P, pellet; +, transfected; -, non-transfected. Arrow marks CP69. CP60 expression is
indistinguishable from that of CP69 (data not shown). (B) Migration of CP1, CP60 and CP69 with respect to endogenous species expressed in COS7, as detected
by R47, shown only in lysates for clarity. Endogenous species sizes are indicated. -, non-transfected. Arrows mark the positions of overexpressed chimeric pro-
teins. (C) Detection of endogenous species by R47 in lymphoblastoid cell line pellets. N, normal karyotype. Endogenous species sizes are indicated, including
full-length DISC1 at 100 kDa. T, translocation. (D) Detection of endogenous species by a-DISC1 in lymphoblastoid cell line lysates. N, normal karyotype; T,
translocation. The asterisk marks the predicted size of the hypothetical translation product of chimeric transcripts arising from the der 11 chromosome.
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597, such as GSK3b (5,36). Phosphodiesterase 4 (10) utilizes
multiple contact sites within amino acids 1–597 that are
sufficient for DISC1/PDE4 interaction (10), but also a C-
terminal site that is abolished by the translocation (37),
which may consequently dysregulate this complex and
dynamic interaction. Altogether, these few examples demon-
strate that expression of C-terminally truncated DISC1 is
likely to have pleiotropic effects at the cellular level. The
importance of this is illustrated by the demonstration that, in
vivo, expression of amino acids 1–597 by in utero electropor-
ation in mice blocks neuronal migration within the developing
cortex (6), whereas its transgenic expression in mice induces
phenotypes resembling characteristics of human mental
illness including enlarged lateral ventricles, and various be-
havioural deficits (38,39). The shortest aberrant species
encoded by transcripts from the der 1 chromosome is CP1,
which essentially corresponds to DISC1 amino acids 1–598.
CP1 localization is indistinguishable from the aberrant local-
ization of amino acids 1–597 (6); thus, we conclude it is a
comparable species that is likely to behave in a similar
manner.
Over and above the multiple effects of expressing amino
acids 1–597, the additional 60 or 69 novel amino acids in
CP60 and CP69 alter the structure of DISC1 amino acids
326–597, leading to the production of larger, more stable
protein assemblies. This is intriguing because detergent-
insoluble DISC1 aggregates have been detected previously in
post-mortem brain samples from psychiatric patients (40,41).
Altogether these observations highlight aberrant DISC1 assem-
bly as a possible disease mechanism in psychiatric illness
(40,41). The abnormal structure of CP60 and CP69 is predicted
to adversely influence protein interactions, and is most likely
related to their extreme effects upon mitochondrial morph-
ology and membrane potential, effects which are not induced
by amino acids 1–597 alone. However, CP60 and CP69 are
very scarce in the translocation-carrying lymphoblastoid cell
lines used in this study, if indeed they are expressed at all, so
these data must be interpreted with caution. That said, we
have demonstrated that even expression of these chimeric pro-
teins at the lowest detectable levels is sufficient to induce mito-
chondrial dysfunction; thus, it is likely that any endogenous
expression of these proteins would be deleterious.
It is not possible to properly assess the contributions of CP1,
CP60 and CP69 to disease pathogenesis in translocation car-
riers until neural material is available for analysis. Induced
pluripotent stem cell technology is the most likely route to
this, and will be available in the not-too-distant future. Until
then, we can only speculate that, because DISC1 is expressed
extensively in the developing and adult brain, and expression
of CP1, CP60 and CP69 is driven by the DISC1 promoter, it is
likely that at some time chimeric transcripts will be produced
at some level in the brain of t(1;11) carriers. Although this spe-
cific disease mechanism is unique to translocation carriers, it is
notable that C-terminal truncation, addition of GFP tags and
the ‘ultra-rare’ putative causal mutation R37W, identified in
a single schizophrenic patient (42), all increase DISC1 mito-
chondrial targeting and induce abnormal morphology
(Ogawa et al., manuscript in preparation) (43), whereas the
schizophrenia-associated variant L607F influences neuronal
mitochondrial transport (44). The psychiatric illness suffered
by translocation carriers displays no unique features, thus it
likely arises from dysregulation of a pathway common to
other unrelated patients. Similarly, the abnormal chimeric
DISC1 species, though unique, may act through a common
pathway. We propose that this common pathway involves
mitochondrial dysfunction. Mitochondria are essential for
multiple processes within most cells, due to their role in the
provision of energy and calcium homeostasis, as well as
their role in apoptosis, either for the clearance of damaged
cells or in programmed cell death. In the brain, neurons are
particularly sensitive to mitochondrial dysfunction, because
mitochondria must be transported to distal dendrites for the
supply of energy and calcium buffering to the synapse (45).
DISC1 is known to be critical for neural precursor prolifer-
ation and differentiation, neuronal migration and integration
and synaptic signalling within the developing and adult
brain (46). It is conceivable that many, if not all, of these pro-
cesses would be compromised by mitochondrial dysfunction,
if the chimeric proteins CP60 and CP69 are indeed expressed
in the brains of t(1;11) translocation carriers, coupled with
reduced expression of DISC1 at other subcellular locations,
such as the synapse, nucleus and centrosome, due to the loss
of normal DISC1 expression from the translocated allele.
MATERIALS AND METHODS
Bioinformatic methods
Chromosome 11 ESTs and DISC1 sequences were examined
using the UCSC genome browser (http://genome.ucsc.edu).
Predicted cDNA produced by the translocation was evaluated
for coding potential, using the ExPASy TRANSLATE tool
(www.expasy.org). Molecular weight calculations were also
carried out using the ExPASy TRANSLATE tool and the
ExPASy Compute Mw tool. Protein secondary structure pre-
dictions were made by submitting amino acid sequences inde-
pendently to PsiPred (23), Jpred3 (22) and Porter (24).
Cell culture and transfection
This study utilized lymphoblastoid cell lines derived from
members of the t(1;11) translocation family, either with a
normal karyotype or carrying the balanced translocation.
Translocation carriers included unaffected family members
as well as those diagnosed with either schizophrenia or
severe recurrent depression. Lymphoblastoid cell lines were
grown in RPMI (Gibco) supplemented with 10% fetal calf
serum (Gibco) under standard conditions, with a 75%
medium change every 2–3 days. Karyotypes of cell lines
used in this study were confirmed by chromosome banding
of metaphase spreads. All lymphoblastoid cell lines were
grown and harvested concurrently to minimize any effects
upon gene expression due to variable growth conditions.
COS7 cells were maintained in Dulbecco’s modified
Eagle’s medium (Invitrogen) containing 10% fetal bovine
serum at 378C in a 5% CO2 humidified atmosphere. Cortical
neuron cultures were prepared from embryonic day (E) 18
mouse fetuses (CD1 or C57BL/6) as described previously
(32), grown on cover slips coated with Poly-D-lysine and
maintained in Neurobasal medium supplemented with 2% of
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B-27 and 2 mM Glutamax (all from Invitrogen) at 378C with
5% CO2. Transfection of cultured cells and cortical neurons
at 5 or 11 DIV was conducted using Lipofectamine 2000 (Invi-
trogen) according to the manufacturer’s instructions.
RT-PCR analysis
RNA was prepared using the Qiagen RNeasy extraction kit,
and cDNA was prepared using the First Strand cDNA synthe-
sis kit (Roche) according to the manufacturer’s instructions.
PCR, to detect novel DISC1 chimeric transcripts, was
carried out using Thermostart Taq polymerase (Abgene). A
typical reaction contains 2 ml of 10× PCR reaction buffer,
1.2 ml of 25 mM magnesium chloride, 0.5 ml of dNTPs (of a
10 mM stock), 0.25 ml of forward and reverse primers (of a
300 ng/ml stock), 0.1 ml of Taq polymerase, 2 ml of DNA tem-
plate and 13.7 ml of sterile water to a final volume of 20 ml.
These reactions were cycled using a touchdown PCR pro-
gramme as follows: [958C, 15 min; 948C, 1 min; 708C, 30 s
(228C/cycle); 728C: 30 s] × 6 cycles, followed by (948C:
1 min; 608C: 30 s; 728C: 30 s) × 34 cycles, or for amplifica-
tion of transcripts encoding CP1: hot start 958C: 2 min, fol-
lowed by (958C: 30 s; 608C: 30 s; 728C: 30 s) × 35 cycles.
Products were resolved using standard agarose gel electro-
phoresis.
For quantitative measurements, DISC1 expression was mea-
sured using the SYBR Green Real-time PCR Detection
System (Bio-Rad Laboratories Ltd). For the quantification of
DISC1 in t(1;11) family cell lines, a single reaction contained
7.5 ml of SYBR Green 2× Master Mix (Bio-Rad Laboratories
Ltd), 0.25–0.5 ml of forward and reverse primers (stock con-
centration of 300 ng/ml), 3 ml of template cDNA and distilled
water to a final volume of 15 ml. The reactions were cycled
using the MyiQ Single-Colour Real-Time PCR Detection
System (Bio-Rad Laboratories Ltd) as follows: 958C: 3 min
(1 cycle); 958C: 10 s; 668C: 30 s; 728C: 45 s (40 cycles), fol-
lowed by melt curve analysis: 558C: 10 s (+0.58C per cycle
for 80 cycles). Relative DISC1 expression levels were calcu-
lated using the MyiQ Gene expression macro (Bio-Rad La-
boratories Ltd), which utilizes the deltaCT method and
corrects for primer amplification efficiencies (http://medgen.
ugent.be/~jvdesomp/genorm) (47). DISC1 expression levels
were normalized using the geometric mean of
Glyceraldehyde-3-phosphate dehydrogenase (Gapdh) and
Phosphofructokinase (PFK), and the use of each housekeeping
gene gave the same results. The same panel of 10 cell lines
(four normal, six translocation) was used for each assay.
Results were obtained for all cell lines in each assay, with
the exception of one translocation cell line when primers spe-
cific for DISC1 exons 4 and 6 were used. This failed assay was
not repeatable since the RNA sample in question was spent.
Data were analysed by two-tailed t-test (GraphPad Prism).
PCR product sequencing
Single PCR products were treated with ExoSAP-IT (GE
Healthcare) prior to direct sequencing. Multiple PCR products
were resolved by LMP agarose gel electrophoresis and
extracted using the QIAquick gel extraction kit (Qiagen)
prior to direct sequencing. Alternatively, purified PCR
products were cloned using the TOPO TA cloning kit (Invitro-
gen) according to the manufacturer’s instructions. BigDye
Terminator sequencing of PCR products or plasmid DNA
was carried out using 1 ml of BDv3.1, 1.5 ml of 5× sequen-
cing buffer, 1 ml of DNA template and 6 ml of dH2-
O. Reactions were cycled as follows: 968C: 1 min (1 cycle);
968C: 10 s; 508C: 5 s; 608C: 4 min (25 cycles); 48C hold. Se-
quencing chromatograms were analysed using Chromas
(version 1.45) (48).
Primer sequences
The primers used to detect DISC1 expression by real-time
PCR in t(1;11) cell lines were as follows: Exon 2 forward 5-
GAACGTGGAGAAGCAGAAGG, reverse 5-CAGAGAAC
TGGAGGAGCCAG; Exons 4–6 forward 5-AGCCTGCACT
TTCAACTTCC, reverse 5-AGTTGCTGCTCTTGCTCCTC;
Exon 9 forward 5-AGAGAGAGAAGGGCTGGAGG,
reverse 5-GTCTCCTGGTGCTCCACTTC.
The housekeeping primers used were as follows: Gapdh
forward 5-GGGAGCCAAAAGGGTCATCA, reverse 5-GTG
GCAGTGATGGCATGGAC; hPFK forward 5-AGAGCGTT
TCGATGATGCTT, reverse 5-GTGTTCCTCCCAGTCG
TCAT.
Primers used to amplify DISC1 chimeric transcripts were as
follows: Derived 1 DISC1 chimeric transcript: Exon 4 DISC1
forward 5-AGCCTGCACTTTCAACTTCC, DISC1FP1 exon
4 reverse 5-AAGACCCACAGATGGAATCG; Derived 1
DISC1 chimeric transcript: Exon 6/7 DISC1 forward 5-AAG
GAGCCTCCAGGAAAGAA, DISC1FP1 exon 3a reverse 5-
CAAGAAATGCCAAAGTGAGTTC; Derived 11 DISC1
fusion with BU599486: exon 2 forward 5-GGGACCTGG
AATTGAAGAGA, DISC1 Exon 9 reverse 5-GTCTCCTGG
TGCTCCACTTC.
Primers used for the mutagenesis of recombinant DISC1/
DISCFP1 chimeric transcripts: forward 5-AAATGCATGC
AATTAGCTAATAAGGCACCACCGATCGTAGTCTG,
reverse 5-CAGACTACGATCGGTGGTGCCTTATTAGCTA
ATTGCATGCATTT.
Plasmid constructs
A pcDNA3.1 expression construct carrying full-length N-
terminally FLAG-tagged DISC1 has been described previous-
ly (37). ORFs encoding human DISC1 amino acids 1–597,
plus the 60 or 69 residues from DISC1FP1 (CP60 or CP69),
were synthesized by GeneArt (Invitrogen) and inserted,
untagged, in pcDNA3.1. To generate tagged versions of
CP60 and CP69, N-terminal FLAG-tags were subsequently
added. N-terminally FLAG-tagged DISC1 amino acids 1–
597 and 1–598 were also in pcDNA3.1.
An ORF encoding N-terminally His-tagged human DISC1
amino acids 326–597, plus the 69 residues from DISC1FP1,
was codon-optimized for expression in E. coli and synthesized
by GeneArt (Invitrogen, Supplementary Material, Fig. S1).
The ORF was recombined sequentially into pDONR-221 (Invi-
trogen) and pETG-40A (A. Geerlof, EMBL) vectors using BP
and LR clonase (Invitrogen), adding an N-terminal MBP tag.
This construct will be referred to as MBP-DNCP69. A control
construct, lacking the additional 69-residues (MBP-DN597),
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was generated by the introduction of two stop codons after the
final wild-type DISC1 residue, using a QuikChange II Site-
Directed Mutagenesis Kit (Agilent Technology). The cloned
constructs were confirmed by sequencing.
Recombinant protein production
Identical expression and purification conditions were used for
MBP-DN597 and MBP-DNCP69. Constructs were first trans-
formed into E. coli BL21 Star (DE3) (Invitrogen) and grown
in 2XTY medium containing 100 mg/ml carbenicillin to an
optical density of 0.6 at 378C (at 600 nm). Protein expression
was induced with 1 mM IPTG (isopropyl b-D-thiogalactoside)
and cultures were grown at 378C for 3 h before harvesting by
centrifugation (5500g, 48C, 15 min) and pellets snap-frozen
and stored at 2708C until required. For purification, bacterial
pellets were spun down and resuspended in amylose-affinity
purification buffer (AAP buffer: 20 mM Tris/200 mM NaCl/
1 mM EDTA/1 mM DTT/10% glycerol, pH 7.4) containing
Complete protease inhibitor cocktail (Roche) at 50 ml of
buffer per litre of culture pellet. Cells were lysed using a TS
Cell Disruptor (Constant Systems, 22 kPsi), centrifuged at 50
000g for 1 h and the supernatant filtered through 0.2 mm
Whatman cellulose nitrate membrane filters. The lysate was
loaded onto an 8 ml amylose-sepharose affinity column (New
England BioLabs), using an A¨KTApurifier (GE Healthcare).
Non-specific proteins were washed out with 10 column
volumes (CV) of AAP buffer and the protein (MBP-DN597 or
MBP-DNCP69) eluted using 10 CV of AAP buffer containing
10 mM maltose. Eluted protein was further purified by size-
based separation using a 320 ml HiLoad 26/60 Superdex
200 pg column (GE Healthcare), to which 1.5 CV of storage
buffer (25 mM HEPES/200 mM NaCl/10% glycerol, pH 7.4 at
108C) was applied. The fractions containing proteins
(MBP-DN597 or MBP-DNCP69) were confirmed by SDS–
PAGE, and were subsequently concentrated using 10 kDa
MWCO Vivaspin Sample Concentrators (Sartorius Stedim
Biotech). The identity of individual SDS–PAGE-purified
protein bands (MBP-DN597 and MBP-DNCP69) was con-
firmed by MALDI-TOF mass spectroscopy, using a Voyager
DE-STR MALDI-TOF mass spectrometer (Applied Biosys-
tems). The spectral data were processed using Data Explorer
software (Applied Biosystems) and the peptide masses searched
using GPMAW 8.0 software (49), after creating a database with
the specific modified sequences of MBP-DN597 and
MBP-DNCP69. The identified peptides, found using
GPMAW, were cross-checked with the observed peaks in the
raw data in Data Explorer and found to match (Supplementary
Material, Fig. S2).
Biophysical characterization
The mean hydrodynamic diameter for each protein batch was
determined by DLS on a Zetasizer Auto Plate Sampler
(Malvern Instruments), with percentage number used as the
output format. Each DLS measurement was performed on puri-
fied protein that was initially centrifuged for 15 min at 24 000g
in a desk-top centrifuge and 100 ml aliquots loaded into a
384-well plate for analysis with the laser set at 830 nm. Size dis-
tribution of each protein construct was determined by
performing three independent runs of three measurements (18
× 10 s readings of each sample) at 108C. DLS is an extremely
sensitive tool for detecting the onset of aggregation resulting
from protein melting and was thus used to estimate the
thermal melting points of the proteins (50) by heating the
sample from 10 to 808C with 28C increments. Results from
three independent batches of each protein (MBP-DNCP69 and
MBP-DN597) were compared by two-tailed, unpaired t-tests.
To investigate secondary structure, protein was desalted into
10 mM phosphate buffer (8 mM Na2HPO4/2 mM NaH2PO4, pH
7.4), using pre-equilibrated PD-10 columns (GE Healthcare)
and then diluted to 0.11 mg/ml (MBP-DNCP69) or 0.12 mg/
ml (MBP-DN597), as measured using a V-550 UV-VIS spectro-
photometer (JASCO) based on absorbance at 280 nm and the
theoretical extinction coefficient of the respective protein
sequences. CD analysis was performed on a J-810 spectropolari-
meter (JASCO) at 258C, using a 0.1 cm cuvette (Starna), and
with wavelengths in the far UV-range of 185–280 nm. Each
CD spectrum represents the average of five scans (data pitch:
0.1 nm; scan speed: 10 nm/min; response time: 2 s) and was cor-
rected by subtraction of the respective spectrum obtained for its
desalted buffer solution (five-scan average accumulation). The
obtained raw spectrum signal was then converted from ellipti-
city (millidegrees) into mean residue ellipticity (degrees cm2
per dmol per residue), to allow for concentration and protein
size-independent spectrum measurement for comparison pur-
poses, using the Spectra Manager software. The spectra were
then submitted to DICHROWEB (21) for deconvolution into
secondary structure components utilizing the analysis programs
CDSSTR or CONTIN (18–20), with reference sets ‘Dataset 3’
or SP175 (17).
Immunocytochemistry
To visualize mitochondria, MitoTracker Red CMXRos (Invi-
trogen) was added to the culture medium at a concentration
of 50 nM and incubated for 30 min at 378C prior to fixation.
Cells were fixed in 3.7% formalin for 10 min at room tempera-
ture, followed by permeabilization with methanol at 2208C
for 5 min. Cells were then blocked in PBS containing 3%
bovine serum albumin for 20 min, and incubated with
primary antibodies for 2 (neurons) or 1 h (COS7) at room tem-
perature on a platform shaker, followed by incubation with
secondary antibodies for 1 h at room temperature. Dilution
of primary antibodies is as follows: anti-FLAG rabbit poly-
clonal (1:5000; Sigma), anti-cytochrome c mouse monoclonal
(1:2000–3000; Mitosciences/Abcam). Secondary antibodies
were Alexa Fluor 488 goat anti-rabbit (A11008) and Alexa
Fluor 647 chicken anti-mouse (1:2000; Invitrogen). Confocal
images were acquired with a Zeiss LSM510 microscope, and
non-confocal images (Supplementary Material, Fig. S3) were
captured using a Zeiss Axioskop 2 MOT epifluorescence
microscope.
Immunoblotting
Lysates were prepared in ice-cold RIPA buffer containing
Complete Protease Inhibitor Cocktail (Roche). Lysates were
solubilized by incubation for 1 h at 48C on a rotary wheel
and centrifuged at 24 000g for 30 min. Following
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centrifugation, pellets were separated from supernatants and
sample buffer added to each. 3–8 or 15% polyacrylamide
gels were used to separate proteins for analysis with the R47
or a-DISC1 antibodies, respectively. Samples were separated
at 150 V and then transferred to PVDF membranes for analysis.
DISC1 R47 (30) and a-DISC1 (35) antibodies were used to
analyse DISC1 protein expression. Prior to incubation with the
R47 primary antibody, membranes were blocked overnight at
48C in PBS 0.2% Tween (PBST) containing 5% Marvel. The
R47 primary antibody was incubated at a 1:100 dilution in
PBST for 1 h at room temperature. Prior to incubation with
a-DISC1, membranes were blocked in TBS 0.1% Tween
(TBST) containing 1% Marvel for 30 min at room tempera-
ture. The a-DISC1 primary antibody was incubated at
1:2000 in TBST/1% Marvel overnight at 48C. Membranes
were washed with either PBST or TBST followed by second-
ary antibody incubation. Goat anti-rabbit secondary antibodies
(HRP conjugates, DakoCytomaten) were incubated at 1:3000
(in PBST or TBST as appropriate) for 20 min at room tem-
perature. Membranes were processed using ECL Plus (GE
Healthcare).
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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